UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022771
Receipt number R000026241
Scientific Title Intervention study to decrease the environmental exposure to tobacco smoke in children
Date of disclosure of the study information 2016/06/17
Last modified on 2018/12/17 09:50:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Intervention study to decrease the environmental exposure to tobacco smoke in children

Acronym

Intervention Study for ETS exposure in children

Scientific Title

Intervention study to decrease the environmental exposure to tobacco smoke in children

Scientific Title:Acronym

Intervention Study for ETS exposure in children

Region

Japan


Condition

Condition

none

Classification by specialty

Not applicable Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To decrease the environmental exposure to tobacco smoke in children

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Cotinine concentration in urine of children

Key secondary outcomes

Questionnaire on smoking habit of the persons living with the children


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Presentation of the urinary concentration of cotinine to the parents to the intervention group. The duration of intervention si 6 months.

Interventions/Control_2

To the control group, the results of cotinine determination will not be presented. General information on smoking-related disease will be presented to the both groups.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Including person(s) who smoke in the family; Living with child younger than 12 years old; Being able to filling in questionnaire in Japanese; having a will to attend the result briefing session after the study.

Key exclusion criteria

Having smoking-related cancers such as pharyngeal, oral, lung, bronchial, esophageal,and stomach cancer; Having respiratory disease.

Target sample size

240


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kunihiko NAKAI

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Development and Environmental Medicine

Zip code


Address

Seiryo 2-1, Aoba-ku, Sendai 980-8575, Japan

TEL

022-717-8949

Email

nakaik@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kunihiko NAKAI

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Development and Environmental Medicine

Zip code


Address

Seiryo 2-1, Aoba-ku, Sendai 980-8575, Japan

TEL

022-717-8949

Homepage URL


Email

nakaik@med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University Graduate School of Medicine, Department of Development and Environmental Medicine

Institute

Department

Personal name



Funding Source

Organization

Smoking Research Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東北大学医学系研究科(宮城県)


Other administrative information

Date of disclosure of the study information

2016 Year 06 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2016 Year 06 Month 15 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 06 Month 16 Day

Last modified on

2018 Year 12 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026241


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name